102 Results for "

PARP2

" in MedChemExpress (MCE) Product Catalog:
Products (102)

102 Results for "PARP2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
375
375 Publications Verification
Art. -Nr.: HY-10162
CAS. Nr.: 763113-22-0
Reinheit:  99.98%
Synonyms: AZD2281; KU0059436
Target:  

PARP Autophagy Mitophagy

Forschungsgebiete:  

Cancer

Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator. Olaparib cannot cross the intact blood-brain barrier (BBB) [2] .
loading...
    loading...
106
106 Cited Publications
Art. -Nr.: HY-16106
CAS. Nr.: 1207456-01-6
Synonyms: BMN-673; LT-673
Target:  

PARP

Forschungsgebiete:  

Cancer

Talazoparib (BMN-673) is a highly potent, orally active PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with Kis of 1.2 nM and 0.87 nM, respectively. Talazoparib has antitumor activity .
loading...
    loading...
87
87 Cited Publications
Art. -Nr.: HY-10619
CAS. Nr.: 1038915-60-4
Reinheit:  99.96%
Synonyms: MK-4827
Target:  

PARP Apoptosis

Forschungsgebiete:  

Cancer

Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [2] .
loading...
    loading...
87
87 Cited Publications
Art. -Nr.: HY-10619B
CAS. Nr.: 1038915-73-9
Reinheit:  99.99%
Synonyms: MK-4827 tosylate
Target:  

PARP Apoptosis

Forschungsgebiete:  

Cancer

Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [2] .
loading...
    loading...
87
87 Cited Publications
Art. -Nr.: HY-10619A
CAS. Nr.: 1038915-64-8
Reinheit:  99.41%
Synonyms: MK-4827 hydrochloride
Target:  

PARP Apoptosis

Forschungsgebiete:  

Cancer

Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [2] .
loading...
    loading...
86
86 Cited Publications
Art. -Nr.: HY-10619E
CAS. Nr.: 1613220-15-7
Reinheit:  99.97%
Synonyms: MK-4827 tosylate hydrate
Target:  

PARP Apoptosis

Forschungsgebiete:  

Cancer

Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib tosylate hydrate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity [2] .
loading...
    loading...
51
51 Cited Publications
Art. -Nr.: HY-10129
CAS. Nr.: 912444-00-9
Reinheit:  99.78%
Synonyms: ABT-888
Target:  

PARP Autophagy

Forschungsgebiete:  

Cancer

Veliparib (ABT-888) is a potent PARP inhibitor, inhibiting PARP1 and PARP2 with Kis of 5.2 and 2.9 nM, respectively .
loading...
    loading...
51
51 Cited Publications
Art. -Nr.: HY-10130
CAS. Nr.: 912445-05-7
Reinheit:  99.98%
Synonyms: ABT-888 dihydrochloride
Target:  

PARP Autophagy

Forschungsgebiete:  

Cancer

Veliparib (dihydrochloride) is a potent inhibitor of PARP1 and PARP2 with Kis of 5.2 nM and 2.9 nM in cell-free assays, respectively.
loading...
    loading...
50
50 Cited Publications
Art. -Nr.: HY-10617A
CAS. Nr.: 283173-50-2
Reinheit:  99.97%
Synonyms: AG014699; PF-01367338
Target:  

PARP

Forschungsgebiete:  

Cancer

Rucaparib (AG014699) is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib has the potential for castration-resistant prostate cancer (CRPC) research [2] .
loading...
    loading...
49
49 Cited Publications
Art. -Nr.: HY-10617
CAS. Nr.: 459868-92-9
Reinheit:  99.56%
Synonyms: AG-014699 phosphate; PF-01367338 phosphate
Target:  

PARP

Forschungsgebiete:  

Cancer

Rucaparib (AG014699) phosphate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib phosphate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib phosphate has the potential for castration-resistant prostate cancer (CRPC) research [2] .
loading...
    loading...
41
41 Cited Publications
Art. -Nr.: HY-102003
CAS. Nr.: 1859053-21-6
Reinheit:  99.82%
Synonyms: AG014699 monocamsylate; PF-01367338 monocamsylate
Target:  

PARP

Forschungsgebiete:  

Cancer

Rucaparib (AG014699) monocamsylate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib monocamsylate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib monocamsylate has the potential for castration-resistant prostate cancer (CRPC) research [2] .
loading...
    loading...
20
20 Cited Publications
Art. -Nr.: HY-132167
CAS. Nr.: 2589531-76-8
Reinheit:  99.76%
Synonyms: AZD5305
Target:  

PARP

Forschungsgebiete:  

Cancer

Saruparib (AZD5305) is a potent, orally active and selective PARP inhibitor and trapper with IC50 values of 3 nM and 1400 nM for PARP1 and PARP2, respectively. Saruparib has anti-proliferative activity and inhibits growth in cells with deficiencies in DNA repair [2].
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-13536
CAS. Nr.: 1174043-16-3
Reinheit:  99.79%
Target:  

PARP

Forschungsgebiete:  

Cancer

AZD-2461 is a potent PARP inhibitor, with IC50s of 5 nM, 2 nM and 200 nM for PARP1, PARP2 and PARP3, respectively.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-104044
CAS. Nr.: 1446261-44-4
Reinheit:  99.97%
Synonyms: BGB-290
Target:  

PARP

Forschungsgebiete:  

Cancer

Pamiparib (BGB-290) is an orally active, potent, highly selective PARP inhibitor, with IC50 values of 0.9 nM and 0.5 nM for PARP1 and PARP2, respectively. Pamiparib has potent PARP trapping, and capability to penetrate the brain, and can be used for the research of various cancers including the solid tumor [2].
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-12975
CAS. Nr.: 1645286-75-4
Reinheit:  99.65%
Target:  

PARP

Forschungsgebiete:  

Cancer

AZ6102 is a potent dual TNKS1 and TNKS2 inhibitor, with IC50s of 3 nM and 1 nM, respectively, and alao has 100-fold selectivity against other PARP family enzymes, with IC50s of 2.0 μM, 0.5 μM, and >3 μM, for PARP1, PARP2, and PARP6, respectively.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-10614
CAS. Nr.: 934162-61-5
Reinheit:  99.00%
Target:  

PARP

Forschungsgebiete:  

Cancer

A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 nM, respectively.
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-12418
CAS. Nr.: 1140964-99-3
Reinheit:  ≥98.0%
Synonyms: E7449; 2X-121
Target:  

PARP

Forschungsgebiete:  

Cancer

Stenoparib (E7449) is a potent PARP1 and PARP2 inhibitor and also inhibits TNKS1 and TNKS2, with IC50s of 2.0, 1.0, ~50 and ~50 nM for PARP1, PARP2, TNKS1 and TNKS2, respectively, using 32P-NAD + as substrate.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-145804
CAS. Nr.: 2756333-39-6
Reinheit:  98.54%
Synonyms: AZD-9574
Target:  

PPAR

Forschungsgebiete:  

Neurological Disease Cancer

AZD-9574 is a potent and brain penetrant PARP1 inhibitor and shows >8000-fold selectivity for PARP1 compared to PARP2/3/5a/6. AZD-9574 acts by selectively inhibiting and trapping PARP1 at the sites of SSBs. AZD-9574 is an anti-cancer agent and can be used for HRD +?breast cancer and advanced solid malignancies research .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-10162R
CAS. Nr.: 763113-22-0
Synonyms: AZD2281 (Standard); KU0059436 (Standard)
Forschungsgebiete:  

Cancer

Olaparib (Standard) is the analytical standard of Olaparib. This product is intended for research and analytical applications. Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator [2] .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-137457
CAS. Nr.: 1681017-83-3
Reinheit:  98.11%
Synonyms: IDX-1197
Target:  

PARP

Forschungsgebiete:  

Cancer

Venadaparib (IDX-1197) is a potent, selective and orally active PARP inhibitor with IC50s of 1.4 nM and 1.0 nM for PARP1 and PARP2, respectively. Venadaparib does not sensitive to PARP-5. Venadaparib prevents the repair of DNA single-strand breaks (SSB) and can be used for solid tumors research [2].
loading...
    loading...